Eligible patients with leukaemia will have access to $25 scripts for two new treatments following their expanded listing on ...
6hon MSN
Photos of 'wonderful' family fun day for 'beautiful' North East two-year-old with rare cancer
The team at the Colliery Inn, Hetton-le-Hole, have hosted a 'heart-warming' event for Avarni-Mae and her parents Chanelle ...
Daily Mail on MSN
Woman accused of faking cancer to scam family out of thousands is added to FBI's most wanted list
Investigators have renewed their search for Vanessa O'Rourke, 37, who allegedly used GoFundMe donations to fund a vacation to ...
By beginning the local manufacturing of CAR-T cells, King Faisal Specialist Hospital & Research Centre (KFSHRC) made a ...
Persistent fatigue, unexplained weight loss, bloating, and chronic pain are among cancer symptoms often mistaken for stress or ageing.
Cellectis doses first patient with BPDCN in phase I study of UCART123: New York Saturday, August 19, 2017, 18:00 Hrs [IST] Cellectis, a clinical-stage biopharmaceutical company fo ...
Joe Longthorne (1955–2019) was an English singer and consummate impressionist whose half-century career made him “one of the ...
Adam Kittai, MD, breaks down the evolving landscape of CLL sequencing—from venetoclax retreatment to triplet regimens. As he ...
In this global phase 3 trial, investigators assessed tafasitamab and lenalidomide plus R-CHOP versus standard-of-care R-CHOP for safety and efficacy in patients with previously untreated DLBCL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results